Purchases and Sales Made in Q4 2024 in Ani Pharmaceuticals Inc (ANIP)
This table provides information about the institutional ownership of Ani Pharmaceuticals Inc (ANIP) during Q4 2024. The information is specifically focused on institutions that hold shares of ANI PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-63.7K- 23.68% |
$3.4M - $3.93M
|
205K
$14.1M
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-69.3K- 28.27% |
$3.7M - $4.28M
|
176K
$12.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-132K- 72.73% |
$7.06M - $8.17M
|
49.6K
$3.41M
|
|
|
Feb 14, 2025
Q4 2024
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-133K- 29.44% |
$7.07M - $8.18M
|
318K
$21.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-175K- 43.54% |
$9.32M - $10.8M
|
227K
$15.6M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-287K- 51.69% |
$15.3M - $17.7M
|
268K
$18.4M
|
|
|
Jan 22, 2025
Q4 2024
|
Pacer Advisors, Inc.
Malvern, PA |
SELL
|
- |
-567K- 99.68% |
$30.2M - $35M
|
1.83K
$126K
|